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ABSTRACT
Introduction: Intestinal protozoa is one of the etiology of gastroenteritis in developing countries. The risk 
of intestinal protozoan infection increases among HIV/AIDS patients. HIV/AIDS patients with CD4+ T cell < 
200 cells/μL are easily infected by intestinal protozoa causing broad clinical symptoms including diarrhea 
and even death. However, it can be prevented by understanding various risk factors which have role in the 
pathogenesis of intestinal protozoan infection.
Objective: To study the prevalence and risk factors which aff ect intestinal protozoan infection among HIV/
AIDS patients in RSUP Dr. Sardjito Yogyakarta.
Methods: Data from 32 HIV/AIDS patients in RSUP Dr Sardjito Yogyakarta in December 2009-March 2010 
were obtained by questionnaires, medical records, and macroscopic-microscopic examination of fecal 
samples with phormol-eter method and acid-fast staining. Data was analysed using Chi square test and 
multivariate analysis. A p value less than 0.05 is considered as a signifi cantly diff erent.
Results: Prevalence of intestinal protozoan infection in HIV/AIDS patients in RSUP Dr Sardjito Yogyakarta was 
81.2%. Intestinal protozoa found in fecal examination were Cryptosporidium sp. (60.98%), Microsporidium 
sp. (19.51%), Entamoeba histolytica (9.76%), Cyclospora cayetanensis (4.88%), Blastocystis hominis (2.44%), 
and Giardia lamblia (2.44%) (n = 26). Bivariate analysis showed that in female HIV/AIDS patients with clinical 
stadium 1 and 2, CD4+ T cell ≥ 200 cells/μL, had lower risk to be infected by intestinal protozoa (RR = 
0.600, 0.065, and 0.026, respectively). Intestinal protozoa were easily found in feces of HIV/AIDS patients 
with diarrheal symptom. In multivariate analysis, clinical stadium was the most signifi cant factor (Exp(β) = 
18.85).
Conclusion: Prevalence of intestinal protozoan infection in HIV/AIDS patients in RSUP Dr Sardjito Yogyakarta 
in December 2009-March 2010 was 81.2%. Clinical stadium with moderate and severe symptoms was the 
most dominant risk factor for intestinal protozoan infection in HIV/AIDS patients.
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INTISARI
Pendahuluan: Protozoa usus merupakan salah satu etiologi gastroenteritis di negara berkembang. Risiko 
terjadinya infeksi protozoa usus meningkat pada penderita HIV/AIDS. Penderita HIV/AIDS dengan CD4 + 
T cell <200 sel / uL akan mudah terinfeksi oleh protozoa usus dan menyebabkan gejala klinis yang luas, 
termasuk diare dan bahkan kematian. Pemahaman akan berbagai faktor risiko yang memiliki peran dalam 
patogenesis infeksi protozoa usus diharapkan dapat membantu usaha preventif.
Tujuan: Penelitian ini bertujuan untuk mengetahui prevalensi dan factor resiko yang menyebabkan 
terjadinya infeksi protozoa usus pada pasien HIV/AIDS di RSUP Dr. Sardjito Yogyakarta.
Metode:  Data didapatkan dari  32 pasien HIV / AIDS di RSUP Dr Sardjito Yogyakarta pada bulan Desember 
2009-Maret 2010. Data diperoleh dengan kuesioner, catatan medis, dan pemeriksaan sampel tinja 
dilakukakan secara makroskopik dan mikroskopik dengan metode phormol-eter dan pewarnaan asam-
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cepat. Data dianalisis menggunakan uji Chi square dan analisis multivariat. Nilai p kurang dari 0,05 dianggap 
sebagai perbedaan yang signifi kan.
Hasil: Prevalensi infeksi protozoa usus pada pasien HIV / AIDS di RSUP Dr Sardjito Yogyakarta adalah 81,2%. 
Protozoa usus yang ditemukan dalam pemeriksaan tinja adalah Cryptosporidium sp. (60.98%), Microsporidium 
sp. (19,51%), Entamoeba histolytica (9.76%), Cyclospora cayetanensis (4,88%), Blastocystis hominis (2,44%), 
dan Giardia lamblia (2,44%) (n = 26). Analisis bivariat menunjukkan bahwa pasien perempuan dengan  HIV 
/ AIDS stadium klinis 1 dan 2, sel CD4 + T ≥ 200 sel / uL, memiliki risiko lebih rendah untuk terinfeksi oleh 
protozoa usus (RR = 0,600, 0,065, dan 0,026).Protozoa usus mudah ditemukan dalam tinja pasien  HIV / AIDS 
dengan gejala diare. Dalam analisis multivariat, stadium klinis merupakan faktor yang paling signifi kan 
(Exp (β) = 18,85
Simpulan: Prevalensi infeksi protozoa usus pada pasien HIV / AIDS di RSUP Dr Sardjito Yogyakarta pada 
bulan Desember 2009-Maret 2010 adalah 81,2%. Stadium klinis dengan gejala sedang dan berat adalah 
faktor risiko yang paling dominan untuk infeksi protozoa usus pada pasien HIV / AIDS.
Kata kunci:  faktor resiko, intestinal protozoa, sel  CD4+ T, pasien HIV/AIDS 
INTRODUCTION
Prevalence of intestinal protozoan infection 
in tropical areas is 50-60% of all population 
in the world. Study on intestinal protozoa in 
Yogyakarta have been reported, with similar 
prevalence between one location to another, that 
is, Entamoeba histolytica 3-11%, Giardia lamblia 
1-8%, Iodamoeba butschlii 1-9%, Endolimax nana 
6-19%, and Entamoeba coli  18-19%1,2,3.
The increased prevalence of new emerging 
infectious diseases and reemerging infectious 
diseases have been associated with the increased 
in HIV/AIDS patients and other diseases related 
to the decrease in body immune system. 
Opportunistic intestinal parasites such as 
Crytosporidium, Isospora belli, Microsporidia, 
Giardia, and Strongyloides stercoralis cause 
malabsorption and chronic diarrhea which result 
in abnormality of intestinal mucosal area. HIV/
AIDS patients with severe diarrhea may lose 
body fluid as many as 3-6 liter daily and they will 
end with death. Diarrhea is particulary occurred 
in HIV and AIDS patients who have CD4+ T cell 
< 200 cells/μL and 26% of them are caused by 
intestinal protozoa4,5,6.
Based on AIDS surveillance data from District 
Health Office of Yogyakarta, the number of HIV 
cases in November 2009 were 590 but 294 of 
them were diagnosed as AIDS patient. Study on 
intestinal protozoan diseases in HIV and AIDS 
patients has not substantially conducted yet, 
except for several types of particular parasites 
such as Toxoplasma gondii and Cryptosporidium. 
The study of other intestinal protozoa in the 
feces of HIV/AIDS patients as the etiology of 
opportunistic infection is need to be clarified.
MATERIALS AND METHODS
It was an analytical observational study with 
cross-sectional design, conducted on 32 HIV/
AIDS patients in RSUP Dr Sardjito Yogyakarta 
in December 2009 until March 2010. Inclusion 
criteria were HIV patients registered in inpatient 
and outpatient units of RSUP Dr Sardjito. 
Exclusion criteria were the use of antiparasitic 
and antibiotic agents within 5-10 days prior 
parasite examination, age 12- 60 years old. 
Secondary data obtained from this study was 
clinical stadium, and CD4+ T cell total number, 
while other data such as gender, educational 
level, economic status, employment status, and 
feces were obtained by interview and direct 
examination. 
HIV and AIDS patient’s fecal sample 
examination was conducted with macroscopic 
25
and microscopic examinations using phormol-
ether method and acid-fast staining to find out 
the types of protozoa in fecal samples. Data was 
analysed using Chi-square test and multivariate 
analysis. A p value less than 0.05 is considered as 
a significantly different.
RESULTS
Characteristics of HIV/AIDS patients are 
summarized in Table 1. Total subjects were 32 
individuals, consisted of 10 inpatients and 22 
outpatients of RSUP Dr Sardjito, Yogyakarta.
From all HIV/AIDS patients, those who 
suffered from intestinal protozoan infection 
were 81.2% and those who didn’t were 18.8%. 
Most common intestinal protozoa in HIV/AIDS 
patient was Cryptosporium sp., found in 25 
patients (60.98%). Complete data on various 
intestinal protozoa found in HIV/AIDS patients 
were shown in Figure 1.
Based on fecal examination, half of HIV/
AIDS patients were not infected by one of 
the intestinal protozoa, but there were some 
patients who had multiple infection. Data of HIV/
AIDS patients infected with single or multiple 
intestinal protozoa infection were shown in 
Table 2.
Characteristics of patients based on CD4+ T 
cells, feces, and intestinal protozoan infection in 
HIV/AIDS patients are shown in Table 3.
Characteristics of HIV/AIDS patients based on 
clinical stadium, feces, and intestinal protozoan 
infection are shown in Table 4.
On Table 4, there were 2 of 7 HIV/AIDS patients 
who were asymptomatic, without diarrhea, with 
positive intestinal protozoa in fecal examination. 
In this study, there were 8 HIV/AIDS patients 
with mild symptoms, 6 of them with diarrhea 
and microscopic examination showed intestinal 
protozoa in all samples. Other 2 patients showed 
no diarrhea, but fecal microscopic examination 
showed 1 sample which positive for intestinal 
protozoa. There were 13 HIV/AIDS patients with 
moderate symptoms, 10 of them with diarrhea 
and fecal microscopic examination found 
intestinal protozoa in all samples. Other 3 patients 
did not have diarrhea, but fecal microscopic 
examination showed intestinal protozoa in all 
samples. From 32 HIV/AIDS patients, only 4 who 
had severe symptoms with diarrhea, and fecal 
microscopic examination showed intestinal 
protozoa in all samples.
Frequency distribution of each risk factor and 
intestinal protozoa infection is shown in Table 5. 
In HIV/AIDS patients < 30 years old, those who 
were infected with intestinal protozoa were 
84.6% and in patients ≥ 30 years old were 78.9% 
(n = 26), while those who were uninfected in < 
30 years old age group were 15.4% and in ≥ 30 
years old age group were 21.1% (n = 6). In this 
study, there were 24 HIV/AIDS patients who 
were males, and 23 of them were infected with 
intestinal protozoa (95.8%) and 1 was uninfected 
(4.2%), while from 8 HIV/AIDS patients who were 
females, 3 were infected (37.5%) and 5 were 
uninfected (62.5%).
There were 5 HIV/AIDS patients with low 
educational level, and all were infected by 
intestinal protozoa; from 27 patients with high 
educational level, there were 21 who were 
infected with intestinal protozoa (77.8%), and 
6 were uninfected (22.2%). In 12 patients who 
had low economic status, all were infected with 
intestinal protozoa and the other 20 had good 
economic status, 14 of them were infected with 
intestinal protozoa (70%) and 6 were uninfected 
(30%). From 32 HIV/AIDS patients, there were 13 
patients who were unemployed, 9 of them were 
infected with intestinal protozoa (75%), and 3 
samples were uninfected (25%), while those 20 
who had employment, 17 of them were infected 
with intestinal protozoa (85%) and 3 were 
uninfected (15%).
In this study, 12 HIV/AIDS patients had no 
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Characteristic Prevalence (%)
Age (years old, average±SD) 32.44 ± 7.01
- Minimum age (years old) 20
- Maximum age (years old) 52
Gender
- Male                                                             24 (75)
- Female 8 (25)
Educational level
- Low                                                          5 (15.6)
- High 27 (84.4)
Economic status
- Low                                                           12 (37.5)
- High 20 (62.5)
Employment status
- Employed 20 (62.5)
? Private employment 7 (21.5)
? Merchant 6 (18.8)
? Laborer 4 (12.5)
? Civil servant 3 ( 9.4)
- Unemployed 12 (37.5)
Feces 
- Diarrhea 20 (62.5)
- Not diarrhea 12 (37.5)
Clinical stadium 
- Asymptomatic 7 (21.9)
- Mild symptom 8 (25.0)
- Moderate symptom 13 (40.6)
- Severe symptom 4 (12.5)
CD4+ T cell (cell/uL, average±SD)                      127.94 ± 173.26
- < 200 cells/μL                                                                                                     25 (78.1)
- 200-499 cells/μL    6 (18.8)
- ≥ 500 cells/μL        1 (3.1)
Intestinal protozoan infection
- Positive                                                                     26 (81.2)
- Negative 6 (18.8)
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Table 1. Characteristics of HIV/AIDS patients in RSUP Dr Sardjito Yogyakarta from December 2009-
March 2010
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Figure 1. Species and percentage of intestinal protozoa among HIV/AIDS patients in 
RSUP Dr. Sardjito Yogyakarta in December 2009-March 2010
Single or multiple infection Total patient
Single infection 12 (46.15%)
Multiple infection 14 (53.85%)
Infection >1 intestinal protozoa, CD4+ T cell <200 cells/μL 13 (92.86%)
Infection >1 intestinal protozoa, CD4+ T cell >199 cells/μL 1 (7.14%)
Infection >1 intestinal protozoa in clnical stadium 1 0 (0%)
Infection >1 intestinal protozoa in clnical stadium 2 5 (35.71%)
Infection >1 intestinal protozoa in clnical stadium 3 5 (35.71%)
Infection >1 intestinal protozoa in clnical stadium 4 4 (28.57%)
Table 2.  Frequency distribution of single or multiple intestinal protozoan 
infection in HIV/AIDS patients in RSUP Dr. Sardjito Yogyakarta in 
December 2009-March 2010
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CD4+ T cell 
(cells/μL)                                                                   Diarrhea Non-diarrhea
TotalIntestinal protozoa
Positive  Negative Positive Negative 
< 200 18 0 5 2 25
Microsporidium sp. 7 0 1 0
Cryptosporidium sp. 18 0 4 0
Cyclospora sp. 1 0 0 0
B. hominis 1 0 0 0
E. histolytica 4 0 0 0
G. lamblia 0 0 1 0
200-499 2 0 1 3 6
Cryptosporidium sp. 2 0 1 0
Cyclospora sp. 1 0 0 0
> 500 0 0 0 1 1
Negative
Total sample 20 0 6 6 32
Table 3.  Frequency and species of intestinal protozoa based on number of CD4+ T cell and diarrhea 
in HIV/AIDS patients in RSUP Dr Sardjito Yogyakarta in December 2009-March 2010
diarrhea, but microscopic examination showed 
intestinal protozoa in 6 samples (50%), and 6 
samples did not show any intestinal protozoa 
(50%). For other 20 patients with diarrhea, in 
microscopic examination there were intestinal 
protozoa in 2 samples (100%). There were 15 
HIV/AIDS patients who were asymptomatic and 
had mild symptoms, 9 of them were infected 
with intestinal protozoa (60%) and 6 samples 
were uninfected (40%). There were 17 patients 
who had moderate and severe symptoms, 
and all were infected with intestinal protozoa 
(100%). From 32 HIV/AIDS patients, there were 
25 patients with CD4+ T cell < 200 cells/μL, 23 
of them were infected with intestinal protozoa 
(92%) and 2 were uninfected (8%), while in 7 
patients with CD4+ T cell ≥ 200 cells/μL, 3 were 
infected with intestinal protozoa (42.9%) and 4 
were uninfected (57.1%).
Chi-square analysis on gender, diarrhea, 
clinical stadium, and CD4+ T cell count of HIV/
AIDS patients were significantly different, with p 
value < 0.05, which meant that gender, diarrhea, 
clinical stadium, and CD4+ T cell were associated 
with intestinal protozoan infection in HIV/AIDS 
patients. OR for gender and CD4+ T cell were 
0.026 and 0.065, respectively, which statistically 
indicated that female were 0.026 times at risk to 
be infected by intestinal protozoa, while patients 
with CD4+ T cell ≥ 200 cells/μL were 0.065 times 
at risk to be infected by intestinal protozoa. RR 
for feces and clinical stadium were 2.000 and 
0.600, respectively, which statistically indicated 
that patients with diarrhea were 2.000 times at 
risk to be infected by intestinal protozoa, while 
patients who were asymptomatic and had mild 
symptoms were 0.600 times at risk to be infected 
by intestinal protozoa.
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Clinical stadium                                                        Diarrhea                    Non-diarrhea Total
Intestinal protozoa
Positive  Negative Positive Negative 
Asymptomatic 0 0 2 5 7
Cryptosporidium sp. 0 0 2 0
Mild symptom 6 0 1 1 8
Microsporidum sp. 4 0 0 0
Cryptosporidium sp. 6 0 1 0
E. histolytica 1 0 0 0
Moderate 
symptom
10 0 3 0 13
Microsporidum sp. 2 0 1 0
Cryptosporidium sp. 10 0 2 0
Cyclospora sp. 1 0 0 0
B. hominis 1 0 0 0
G. lamblia 0 0 1 0
Severe symptom 4 0 0 0 4
Microsporidum sp. 1 0 0 0
Cryptosporidium sp. 4 0 0 0
E. histolytica 3 0 0 0
Total sample 20 0 6 6 32
Table 4.  Frequency and types of intestinal protozoa based on clinical stadium and feces in HIV/AIDS 
patients in RSUP Dr Sardjito Yogyakarta in December 2009-March 2010
Variables of age, educational level, 
economic status, and employment status were 
insignificantly different, with p value of 1.00, 
0.555, 0.61, and 0.647, respectively, which 
meant that there were no association between 
age, educational level, economic status, and 
employment status of HIV/AIDS patients. Age 
group < 30 years old, low educational level, low 
economic status, and employed group had higher 
possibility to be infected by intestinal protozoa.
From all data obtained, to determine 
the most dominant risk factor for intestinal 
protozoan infection, multivariate analysis with 
logistic regression was conducted. Result of the 
total analysis of risk factors of HIV/AIDS patients 
for intestinal protozoan infection is shown in 
Table 6.
Table 6 shows that gender, diarrhea, 
moderate and severe symptom clinical stadium, 
and CD4+ T cell < 200 cells/μL were associated 
with intestinal protozoan infection in HIV/AIDS 
patients with p value < 0.05. Moderate and 
severe symptom clinical stadium had highest 
Exp(β) of 18.85, compared with other 3 risk 
factors (0.000, 0.016, 0.909), which statistically 
indicated that clinical stadium with moderate 
and severe symptoms was the most dominant 
risk factor for intestinal protozoan infection in 
HIV/AIDS patients.
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Variables
Intestinal protozoan infection p Odds ratio    (OR)
Positive (n=26)   Negative (n=6) (CI = 95%)
Age ≥ 30 years old 15 (78.9%) 4 (21.1%)
1.000 0.682
Age < 30 years old 11 (84.6%)   2 (15.4%)   
Female 3 (37.5%) 5 (62.5%)
0.002* 0.026
Male 23 (95.8%) 1 (  4.2%)  
Low educational level 5 (100%) 0 (  0.0%)
0.555 1.286
High educational level 21 (77.8%) 6 (22.2%)
High economic status 14 (70.0%) 6 (30.0%)
0.061 0.700
Low economic status 12  (100%) 0 (0.0%)
Unemployed 9 (75.0%) 3 (25.0%)
0.647 0.529
Employed 17 (85.0%) 3 (15.0%)
Diarrhea 20  (100%) 0 (  0.0%)
0.001* 2.000
No diarrhea 6 (50.0%) 6 (50.0%)
Stadium I (asymptomatic and 
mild symptoms) 9 (60.0%) 6 (40.0%)
0.006* 0.600
Stadium II (Moderate and 
severe symptoms) 17  (100%) 0 (  0.0%)
CD4+ T cell ≥ 200 cells/μL 3 (42.9%) 4 (57.1%)
0.012* 0.065
CD4+ T cell < 200 cells/μL 23 (92.0%) 2 (  8.0%)
Table 5. Relationship between each risk factor and intestinal protozoan infection in HIV/AIDS 
patients in RSUP Dr Sardjito Yogyakarta in December 2009-March 2010
Note: * p value was significantly different if < 0.05
DISCUSSION
Prevalence of intestinal protozoa in HIV/
AIDS patients in RSUP Dr Sardjito Yogyakarta in 
December 2009-March 2010 was 26 patients 
(81.2%), and there were 6 who were uninfected 
(18.8%). The most dominant protozoa that 
had role in the infection in this study was 
Cryptosporidium sp. (25 patients, 60.98%), 
followed by Microsporidium sp (8 patients, 
19.51%), E. histolytica (4 patients, 9.76%), 
Cyclospora sp. (2 patients, 4.88%), and B. 
hominis and G. lamblia (1 patient each, 2.44%). 
In this study, prevalence of intestinal protozoa 
infection was different from that in the previous 
study, and other pathogenic intestinal protozoa 
weren’t found, such as in India, which found that 
Variable p value Exp (β)
Male 0.000* 0.000
Diarrhea 0.000* 0.016
Moderate and severe 
clinical symptoms
0.004* 18.85
CD4+ T cell < 200 cells/μL 0.003* 0.909
Table 6. Analysis result of the most dominant risk 
factors of intestinal potozoan infection 
in HIV/AIDS patients in RSUP Dr Sardjito 
Yogyakarta in December 2009-March 
2010
Note : * p value is significantly different if < 
0.05
Exp (β) = Odds ratio of risk factor for intestinal 
protozoan infection
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the intestinal protozoa in HIV/AIDS patients were 
Cryptosporidium sp. (75%), G. lamblia (32%), 
Microsporidium sp (13.3%), and I. belli (5.3%), of 
75 samples10.
Multiple infection by intestinal protozoa 
commonly found in HIV/AIDS patients was 
caused by Cryptosporidium sp; this intestinal 
protozoa  was possibly the cause of diarrhea, 
although it might infect patients without any 
diarrhea or those who had adequate immunity. 
Cryptosporidium sp mostly infects children, 
elderly, and AIDS patients who have low 
immunity, and it may cause malabsorption and 
chronic diarrhea. HIV/AIDS patients with CD4+ T 
cell < 200 cells/μL had more multiple infection 
(13 patients, 92.86%) compared with patients 
with CD4+ T cell ≥ 200 cells/μL (1 patient, 7.14%). 
Multiple infection is occurred because of latent 
phase of HIV, results in a decrease in CD4+ T cells 
and destruction of those cells in lymphatic nodes. 
Similar study found protozoan infection in HIV/
AIDS patients with average age of 38 years old 
in France, such as Cryptosporidium sp (37.3%), B. 
hominis (13.7%), G. lamblia (5.6%), I. belli (2%), 
Microsporidium (2%), and E. histolytica (2%) from 
81 patients with multiple infection (38.3%)11.
Average age of HIV/AIDS patients in this study 
was 32.44 years old, with minimum age of 20 years 
old and maximum age of 52 years old. There were 
13 patients in < 30 years old the age group (20-
30 years old), and there were 84.6% who were 
infected with intestinal protozoa. There were 19 
patients in ≥ 30 years old age group (30-52 years 
old), and there were 78.9% who were infected 
with intestinal protozoa. Bivariate analysis 
on age group showed insignificant difference 
with p value of 1.000 and OR = 0.682, which 
meant that there was no association between 
age and intestinal protozoan infection in HIV/
AIDS patients in RSUP Dr Sardjito Yogyakarta in 
December 2009-March 2010, but clinically, the 
probability of ≥ 30 years old age group to have 
intestinal protozoan infection was 0.682. 
HIV/AIDS patients included in this study were 
adults. In this age, the body imunity is higher, 
because it has been developed completely 
and repeated infections through their life 
has increased the development of antibody. 
Meanwhile, in children, immunity has not been 
developed completely, and in elderly there is 
poor absorption of nutrition, which decreases 
the cellular response, such as lymphocyte 
proliferation, cytokine synthesis, and response 
of antibody. Similar result in Nigeria showed that 
the age of HIV/AIDS was insignificantly different, 
with total intestinal protozoan infection for 20-
30 years old age group was 32.9% and for > 30 
years old age group was 26.3%. Other study also 
found the prevalence of intestinal protozoa in 
patients who did not have HIV/AIDS for 0-9 years 
old age group was 28%, for 20-40 years old age 
group was 20%, and for > 50 years old age group 
was 31%12,13,14.
There were 24 male HIV/AIDS patients in 
RSUP Dr Sardjito Yogyakarta in December 
2009-March 2010 and there were 95.8% who 
were infected with intestinal protozoa, and 
there were 8 females with 37.5% of them 
were infected. Bivariate analysis of gender risk 
factor showed that gender was associated with 
intestinal protozoan infection, with p value of 
0.002 and OR = 0.026. It showed that gender 
was one of the factors of intestinal protozoan 
infection in HIV/AIDS patients, but clinically, 
female had 0.026 times the risk to have intestinal 
protozoan infection, which meant that males 
was easier to be infected by intestinal protozoan 
infection compared with females. It may be 
caused by androgen hormone in males which 
are immunosuppressive, while women have 
estrogen which promote the increase in the 
immunity to infection. Similar study in Nigeria 
showed that gender of HIV/AIDS patients was 
significantly different, with 9 male infected (60%) 
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and 6 females infected (40%)12,13.
Educational level of HIV/AIDS patients in 
RSUP Dr Sardjito Yogyakarta in December 2009-
March 2010 was considered low in 5 patients 
and all were infected with intestinal protozoa, 
while 27 patients with high educational level had 
77.8% infection by intestinal protozoa. Bivariate 
analysis of educational level showed that it 
was not associated with intestinal protozoan 
infection, with p value of 0.0555 and OR = 1.286. 
It showed that educational level was not a risk 
factor of intestinal protozoan infection in HIV/
AIDS patients, although clinically patients with 
low educational level had 1.286 times the risk to 
be infected by intestinal protozoa compared with 
patients with high educational level. Patients 
with low educational level was easier to be 
infected by intestinal protozoa, which probably 
caused by the lack of knowledge about self- and 
environmental hygiene related with intestinal 
protozoa life cycle. Other study in Iran suggested 
that there was no significant association between 
education and intestinal protozoan infection6,14.
Economic status of HIV/AIDS patients in RSUP 
Dr Sardjito Yogyakarta in December 2009-March 
2010 was grouped by Regional MinimumWage 
of Rp 700.000,00, and it was found that there 
were 12 patients with low economic status and 
all of them were infected by intestinal protozoa; 
and there were 20 patients with good economic 
status and 70% were infected. Bivariate analysis 
of economic status showed that it was not 
associated with intestinal protozoan infection, 
with p value of 0.061 and OR = 0.700. The result 
of the analysis showed that economic status was 
not a risk factor for intestinal protozoa infection 
in HIV/AIDS patients, although clinically patients 
with good economic status had probabiity of 
0.700 to be infected by intestinal protozoa 
compared with low economic status, which 
meant that patients with low economic status 
were easily infected by intestinal protozoa. This 
was made possible by the lack of nutrition as the 
support for the development of body immunity 
and the lack of support facility for self-, house 
and environmental hygiene. Previous study in 
Ethiopia showed that low economic status were 
easily infected by intestinal protozoa (86%) 
compared with patients with good economic 
status (14%)6,15.
Employment status of HIV/AIDS patients in 
RSUP Dr Sardjito Yogyakarta in December 2009-
March 2010 consisted of employed (12 patients, 
37.5%) and unemployed (12 patients, 37.5%). 
In employed group, 85% were infected with 
intestinal protozoa, while in unemployed group, 
there were 75% who were infected. Bivariate 
analysis showed that employment status 
was not associated with intestinal protozoan 
infection with p value of 0.647 and OR = 0.529. 
It showed that employment status was not a risk 
factor for intestinal protozoan infection in HIV/
AIDS patients, although clincally, unemployed 
patients had 0.529 times the risk to be infected 
by intestinal protozoa compared to whose who 
were employed. Infection in employed patients 
were higher because of the contact of HIV/
AIDS patients with infective form of protozoa 
around the occupational environment and 
aggravated with the low immunity of HIV/AIDS 
patients. Previous study in Iraq conducted for a 
year showed that intestinal protozoan infection 
was occurred in laborers (19%) and those who 
worked in the office (10.5%), with p > 0.0514,16.
There were 20 HIV/AIDS patients with 
diarrhea in RSUP Dr Sardjito Yogyakarta, and all 
of them were infected by intestinal protozoa, 
while 12 non diarrheal patients showed 50% 
infection. Bivariate analysis on feces of the 
patients showed that it was not associated with 
intestinal protozoan infection, with p value of 
0.001 and OR = 2.000. This analysis showed that 
intestinal protozoa were easier to be found in 
diarrheal patients with 2.000 times higher risk 
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compared with non-diarrheal patients. It was 
caused by the decrease in CD4+ T cells of HIV/
AIDS patients. This is consistent with previous 
study which found that there was a significant 
association between diarrhea and intestinal 
protozoan infection in 99 patients with frequency 
of 51%, and mostly caused by Cryptosporidium 
sp17.
In this study, clinical stadium was classified 
into stadium I (asymptomatic and mild 
symptoms), which found in 15 patients (46.9%) 
and 60% of them were infected by intestinal 
protozoa; and stadium II (moderate and severe 
symptoms), which found in 17 patients (53.1%) 
and all of them were infected. Bivariate analysis 
on the clinical stadium showed that it was 
associated with intestinal protozoan infection 
with p value of 0.006 and OR = 0.600. The result 
of the analysis showed that clinical stadium was 
a risk factor of intestinal protozoan infection in 
HIV/AIDS patients, and clinically, patients who 
were asymptomatic or had mild symptoms had 
0.600 times risk to be infected by intestinal 
protozoa, which meant that patients with 
moderate and severe symptoms were easier to 
be infected by intestinal protozoa. This result was 
consistent with WHO guideline which suggested 
that opportunistic infection in HIV/AIDS patients 
was occurred in clinical stadium 3 and 4.
CD4+ T cells in this study was classified into < 
200 cells/μL, which found in 25 patients and 92% 
of them were infected; and ≥ 200 cells/μL, which 
found in 7 patients, and 42.9% were infected 
with intestinal protozoa. Bivariate analysis of 
CD4+ T cells risk factor showed that it was 
associated with intestinal protozoan infection, 
with p value of 0.012 and OR = 0.065. Result of 
the analysis showed that CD4+ T cells was a risk 
factor of intestinal protozoan infection in HIV/
AIDS patients, and clinically patients who had 
CD4+ T cells ≥ 200 cells/μL had 0.065 times risk 
to be infected by intestinal protozoa, compared 
with HIV/AIDS patients who had CD4+ T cells < 
200 cells/μL who were easier to be infected.
Result of the study on HIV/AIDS patients 
in RSUP Dr Sardjito Yogyakarta in December 
2009-March 2010 showed that clinical stadium 
in HIV/AIDS patients had highest value, with 
Exp(β) = 18.85. It also showed that clinical 
stadium was the most dominant risk factor 
for intestinal protozoan infection in HIV/AIDS 
patients. This is consistent with WHO statement 
that opportunistic infection, including intestinal 
protozoa, was occurred when HIV/AIDS patients 
were in clinical stadium 3 with moderate 
symptoms.
CONCLUSION
Prevalence of intestinal protozoan infection 
in HIV/AIDS patients in RSUP Dr Sardjito 
Yogyakarta in December 2009-March 2010 
was 81.2%. Clinical stadium with moderate and 
severe symptoms was the most dominant risk 
factor for intestinal protozoan infection in HIV/
AIDS patients.
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